Cognitive Performance and Psychological Distress in Breast Cancer Patients at Disease Onset

被引:30
作者
Kaiser, Jochen [1 ]
Dietrich, Joerg [2 ]
Amiri, Miena [1 ]
Rueschel, Isa [1 ]
Akbaba, Hazal [1 ]
Hantke, Nonda [1 ]
Fliessbach, Klaus [3 ,4 ]
Senf, Bianca [5 ]
Solbach, Christine [6 ]
Bledowski, Christoph [1 ]
机构
[1] Goethe Univ Frankfurt, Inst Med Psychol, Frankfurt, Germany
[2] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA
[3] Univ Bonn, Med Ctr, Dept Neurodegenerat Dis & Geriatr Psychiat, Bonn, Germany
[4] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany
[5] Univ Hosp Frankfurt Main, Univ Canc Ctr, Dept Psychooncol, Frankfurt, Germany
[6] Univ Hosp Frankfurt Main, Dept Gynecol & Obstet, Senol Unit, Frankfurt, Germany
来源
FRONTIERS IN PSYCHOLOGY | 2019年 / 10卷
关键词
breast cancer; cognitive functions; psychological distress; attention; memory;
D O I
10.3389/fpsyg.2019.02584
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Objective: Many cancer patients complain about cognitive dysfunction. While cognitive deficits have been attributed to the side effects of chemotherapy, there is evidence for impairment at disease onset, prior to cancer-directed therapy. Further debated issues concern the relationship between self-reported complaints and objective test performance and the role of psychological distress.Method: We assessed performance on neuropsychological tests of attention and memory and obtained estimates of subjective distress and quality of life in 27 breast cancer patients and 20 healthy controls. Testing in patients took place shortly after the initial diagnosis, but prior to subsequent therapy.Results: While patients showed elevated distress, cognitive performance differed on a few subtests only. Patients showed slower processing speed and poorer verbal memory than controls. Objective and self-reported cognitive function were unrelated, and psychological distress correlated more strongly with subjective complaints than with neuropsychological test performance.Conclusion: This study provides further evidence of limited cognitive deficits in cancer patients prior to the onset of adjuvant therapy. Self-reported cognitive deficits seem more closely related to psychological distress than to objective test performance.
引用
收藏
页数:9
相关论文
共 67 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] Cognitive function in breast cancer patients prior to adjuvant treatment
    Ahles, Tim A.
    Saykin, Andrew J.
    McDonald, Brenna C.
    Furstenberg, Charlotte T.
    Cole, Bernard F.
    Hanscom, Brett S.
    Mulrooney, Tamsin J.
    Schwartz, Gary N.
    Kaufman, Peter A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 110 (01) : 143 - 152
  • [3] Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls
    Ando-Tanabe, Noriko
    Iwamitsu, Yumi
    Kuranami, Masaru
    Okazaki, Shigemi
    Yasuda, Hiroe
    Nakatani, Yuki
    Yamamoto, Kenji
    Watanabe, Masahiko
    Miyaoka, Hitoshi
    [J]. BREAST CANCER, 2014, 21 (04) : 453 - 462
  • [4] Cancer, coping, and cognition: a model for the role of stress reactivity in cancer-related cognitive decline
    Andreotti, Charissa
    Root, James C.
    Ahles, Tim A.
    McEwen, Bruce S.
    Compas, Bruce E.
    [J]. PSYCHO-ONCOLOGY, 2015, 24 (06) : 617 - 623
  • [5] Stress weakens prefrontal networks: molecular insults to higher cognition
    Arnsten, Amy F. T.
    [J]. NATURE NEUROSCIENCE, 2015, 18 (10) : 1376 - 1385
  • [6] Cognitive impairment associated with adjuvant therapy in breast cancer
    Bender, Catherine M.
    Sereika, Susan M.
    Berga, Sarah L.
    Vogel, Victor G.
    Brufsky, Adam M.
    Paraskar, Karen K.
    Ryan, Christopher M.
    [J]. PSYCHO-ONCOLOGY, 2006, 15 (05) : 422 - 430
  • [7] Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study
    Biglia, N.
    Bounous, V. E.
    Malabaila, A.
    Palmisano, D.
    Torta, D. M. E.
    D'Alonzo, M.
    Sismondi, P.
    Torta, R.
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2012, 21 (04) : 485 - 492
  • [8] Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response
    Boykoff, Nelli
    Moieni, Mona
    Subramanian, Saskia Karen
    [J]. JOURNAL OF CANCER SURVIVORSHIP, 2009, 3 (04) : 223 - 232
  • [9] Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer
    Cimprich, B
    Ronis, DL
    Trask, C
    [J]. PSYCHO-ONCOLOGY, 2005, 14 (01) : 70 - 78
  • [10] ATTENTIONAL FATIGUE FOLLOWING BREAST-CANCER SURGERY
    CIMPRICH, B
    [J]. RESEARCH IN NURSING & HEALTH, 1992, 15 (03) : 199 - 207